Influenza Vaccine Market Analysis

Age Group (Pediatric, Adult)

The global market is segmented and analyzed for demand and supply by age group into paediatric and adult. Among these segments, the paediatric segment is anticipated to capture the largest market size in the global influenza vaccine market owing to the higher burden of flu among children aged below 5 years old. Centers for Disease Control and Prevention reports that in 2021 children younger than 5 years old were affected by 44% of flu cases. A total of 56% of deaths among children aged 5-17 were caused by the flu. Moreover, the increasing awareness among parents about safeguarding their children against infectious diseases, such as influenza coupled with children's weak immune systems is anticipated to augment segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

By Type	Quadrivalent Trivalent
By Technology	Egg-based Cell Culture
By Age Group	Pediatric Adult
By Route of Administration	Injection Nasal Spray
By End User	Hospitals Pharmacies Government Vaccination Centers

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of influenza vaccine is estimated at USD 7.32 billion.

The influenza vaccine market size was over USD 6.92 billion in 2024 and is poised to cross USD 17.01 billion by the end of 2037, growing at more than 7.1% CAGR during the forecast period i.e., between 2025-2037. Rapid spread of influenza virus, rising COVID-19 cases, increasing healthcare spending along with incidence of chronic diseases among people will boost the market growth.

North America industry is projected to hold majority revenue share by 2037, impelled by rapid spread of the influenza A virus among the population, new product launches, and expansion of services for product distribution in the region.

The major players in the market include BioDiem Ltd., SANOFI, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., Emergent BioSolutions Inc., CSL Limited, Johnson & Johnson Services, Inc., Astellas Pharma Inc.

Influenza Vaccine Market Analysis